PRIOR PRINTER'S NO. 1675

PRINTER'S NO.  1854

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

HOUSE BILL

 

No.

838

Session of

2011

  

  

INTRODUCED BY BEAR, TURZAI, DERMODY, SAYLOR, HANNA, AUMENT, CARROLL, CLYMER, COHEN, D. COSTA, P. COSTA, CUTLER, FABRIZIO, FLECK, GEIST, GERGELY, GILLESPIE, GINGRICH, GOODMAN, HARKINS, HESS, HORNAMAN, KILLION, KOTIK, MANN, MARSICO, MILLARD, MILNE, MOUL, MURT, D. O'BRIEN, PARKER, PAYTON, SCAVELLO, M. SMITH, SONNEY, STURLA, SWANGER, TOEPEL, FARRY, WHITE, DiGIROLAMO AND DAVIS, APRIL 28, 2011

  

  

AS REPORTED FROM COMMITTEE ON PROFESSIONAL LICENSURE, HOUSE OF REPRESENTATIVES, AS AMENDED, MAY 11, 2011   

  

  

  

AN ACT

  

1

Amending the act of June 6, 1980 (P.L.197, No.57), entitled "An

2

act regulating the licensure and practice of optometry,

3

making repeals and providing penalties," defining "ophthalmic

4

surgery"; and further defining "practice of optometry."

5

The General Assembly of the Commonwealth of Pennsylvania

6

hereby enacts as follows:

7

Section 1.  The definition of "practice of optometry" in

8

section 2 of the act of June 6, 1980 (P.L.197, No.57), known as

9

the Optometric Practice and Licensure Act, amended December 16,

10

2002 (P.L.1950, No.225), is amended and the section is amended

11

by adding a definition to read:

12

Section 2.  Definitions.

13

The following words and phrases when used in this act shall

14

have, unless the context clearly indicates otherwise, the

15

meanings given to them in this section:

16

* * *

 


1

"Ophthalmic surgery."  A treatment or procedure, diagnostic,

2

palliative, therapeutic, rehabilitative, cosmetic or refractive,

3

for conditions or disease processes involving the eye or ocular

4

adnexa, utilizing lasers, cautery, ionizing or nonionizing

5

radiation, scalpels, probes, needles or other instruments in

6

which the human eye or ocular adnexa is cut, drained,

7

penetrated, thermally altered, vaporized, frozen, sutured,

8

probed, injected or otherwise altered by any mechanical,

9

thermal, light-based, electromagnetic, radiofrequency,

10

ultrasonic, chemical or pharmacologic means. The term does not

11

include the application of warm or cold compresses; the

12

insertion and removal of punctal plugs; punctal dilation and

13

irrigation of the lacrimal system; the removal of superficial

14

foreign bodies; epilation of eyelashes; orthokeratology; the

15

diagnostic use of light, laser or ultrasound for imaging or

16

measurement purposes; ophthalmoscopy, direct and indirect;

<--

17

biomicroscopy; optical coherence tomography; digital

18

photography, anterior or posterior; glare recovery testing;

19

testing pigmentary optical density; perimetry; peripheral

20

hyperacuity perimetry; optos testing; any automated screen

21

testing, including contrast sensitivity testing; color vision

22

testing; auto or manual refraction; auto or manual keratometry;

23

contact lens evaluations; any assessment of the ocular adnexa by

24

palpation to assess skin temperature; tonometry (IOP

25

assessments); scleral indentation; expressing Meibomian glands

26

and lid lesions without incision; pachymetry; A/B ultrasonic

27

scans; corneal sensitivity testing; orthokeratology and corneal

28

reshaping with Paragon CRT; corneal topography; gonioscopy;

29

vision therapy; vision rehabilitation; vision screening; corneal

30

curvature measurements; static retinoscopy; electrodiagnostic

- 2 -

 


1

testing; or treatments or the use of instruments or performance

2

of procedures that are authorized by law or regulation as of the

3

effective date of this definition. The term shall not be

4

construed to affect the administration and prescription of

5

additional drugs as may be approved on or after the effective

6

date of this definition by the Secretary of Health as provided

7

in section 4.3(3).

8

* * *

9

"Practice of optometry."

10

(1)  The use of any and all means or methods for the

11

examination, diagnosis and treatment of conditions of the

12

human visual system and shall include the examination for,

13

and adapting and fitting of, any and all kinds and types of

14

lenses including contact lenses.

15

(2)  The administration and prescription of legend and

16

nonlegend drugs as approved by the Secretary of Health as

17

provided in section 4.3 for treatment of the eye, the

18

eyelids, the lacrimal system and the conjunctiva and the

19

removal of superficial foreign bodies from the ocular surface

20

and adnexa so long as treatment of diseases or conditions of

21

the visual system, other than glaucoma, as authorized under

22

this paragraph shall not continue beyond six weeks from the

23

initiation of treatment unless the prescribing optometrist

24

documents consultation with a licensed physician. As used in

25

this paragraph, the initiation of treatment may, but need

26

not, include the prescription or administration of

27

pharmaceutical agents for therapeutic purposes.

28

(3)  The term shall not include:

29

(i)  surgery, including, but not limited to,

30

ophthalmic surgery or laser surgery; the use of lasers

- 3 -

 


1

for therapeutic purposes; and the use of injections in

2

the treatment of ocular disease;

3

(ii)  the use of Schedule I and Schedule II

4

controlled substances;

5

(iii)  treatment of systemic disease; and

6

(iv)  the treatment of glaucoma, except that

7

optometrists may use all topical pharmaceutical agents in

8

the treatment of primary open angle glaucoma, exfoliation

9

glaucoma and pigmentary glaucoma.

10

* * *

11

Section 2.  This act shall take effect in 60 days.

- 4 -